Clinical trials
Phase 1 Cognition Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 4 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AlzeCure Pharma | 3 |
| Janssen Pharmaceutica N.V., Belgium | 3 |
| Siena Biotech S.p.A. | 2 |
| Abbott | 1 |
| Alen Greš | 1 |
| Alzheimer's Disease Expert Lab (ADEL), Inc. | 1 |
| Assaf-Harofeh Medical Center | 1 |
| Libella Gene Therapeutics | 1 |
| NXTech | 1 |
| National Institute of Mental Health (NIMH) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognition Disorders | 23 |
| Alzheimer Disease | 6 |
| Cognitive Dysfunction | 5 |
| Schizophrenia | 5 |
| Dementia | 4 |
| Mental Disorders | 4 |
| Brain Diseases | 3 |
| Central Nervous System Diseases | 3 |
| Nervous System Diseases | 3 |
| Neurodegenerative Diseases | 3 |
Trials
Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.